Althani, A.A., Marei, H.E., Hamdi, W.S., Nasrallah, G.K., El Zowalaty, M.E., Al Khodor, S., Al-Asmakh, M., Abdel-Aziz, H. and Cenciarelli, C., 2016. Human microbiome and its association with health and diseases. Journal of Cellular Physiology 231: 1688-1694.

'Human microbiome and its association with health and diseases ' () 231 Journal of Cellular Physiology : 1688 -1694.

Human microbiome and its association with health and diseasesJournal of Cellular Physiology23116881694)| false
• 检索谷歌学术

Awadel-Kariem,F.M., Patel, P., Kapoor, J., Brazier, J.S. and Goldstein, E.J.C., 2010. First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection. Anaerobe 16: 223-225.

'First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection ' () 16 Anaerobe : 223 -225.

First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infectionAnaerobe16223225)| false
• 检索谷歌学术

Beidler, S.K., Douillet, C.D., Berndt, D.F., Keagy, B.A., Rich, P.B. and Marston, W.A., 2009. Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. Journal of Vascular Surgery 49:1013-1020.

'Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy ' () 49 Journal of Vascular Surgery : 1013 -1020.

Inflammatory cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapyJournal of Vascular Surgery4910131020)| false
• 检索谷歌学术

Byun, S.J., Lim, T.J., Lim, Y.J., Seo, J.G. and Chung, M.J., 2016. In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin. Beneficial Microbes 7: 731-737.

'In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacin ' () 7 Beneficial Microbes : 731 -737.

In vivo effects of s-pantoprazole, polaprenzinc, and probiotic blend on chronic small intestinal injury induced by indomethacinBeneficial Microbes7731737)| false
• 检索谷歌学术

Carding, S., Verbeke, K., Vipond, D.T., Corfe, D.M. and Owen, L.J., 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease 26: 26191.

'Dysbiosis of the gut microbiota in disease ' () 26 Microbial Ecology in Health and Disease : 26191.

Dysbiosis of the gut microbiota in diseaseMicrobial Ecology in Health and Disease2626191)| false
• 检索谷歌学术

Chassard, C., Dapoigny, M., Scott, K.P., Crouzet, L., Del’homme, C., Marquet, P., Martin, J.C., Pickering, G., Ardid, D., Eschalier, A., Dubray, C., Flint, H.J. and Bernalier-Donadile, A., 2012. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 35: 828-838.

'Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome ' () 35 Alimentary Pharmacology and Therapeutics : 828 -838.

Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndromeAlimentary Pharmacology and Therapeutics35828838)| false
• 检索谷歌学术

Cohen, S., Cannon, G.W., Schiff, M., Weaver, A., Fox, R., Olsen, N., Furst, D., Sharp, J., Moreland, L., Caldwell, J., Kaine, J. and Strand, V., 2001. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis and Rheumatism 44: 1984-1992.

'Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate ' () 44 Arthritis and Rheumatism : 1984 -1992.

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexateArthritis and Rheumatism4419841992)| false
• 检索谷歌学术

Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., Grondin, V., Jouet, P., Bouhassira, D., Seksik, P., Sokol, H., Coffin, B. and Sabate, J.M., 2012. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterology and Motility 24: 513-520.

'Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome ' () 24 Neurogastroenterology and Motility : 513 -520.

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndromeNeurogastroenterology and Motility24513520)| false
• 检索谷歌学术

Gill, S.R., Pop, M., DeBoy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M. and Nelson, K.E., 2006. Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.

'Metagenomic analysis of the human distal gut microbiome ' () 312 Science : 1355 -1359.

Metagenomic analysis of the human distal gut microbiomeScience31213551359)| false
• 检索谷歌学术

Guinane, C.M. and Cotter, P.D., 2013. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology 6: 295-308.

'Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ ' () 6 Therapeutic Advances in Gastroenterology : 295 -308.

Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organTherapeutic Advances in Gastroenterology6295308)| false
• 检索谷歌学术

Kverka, M., Zakostelska, Z., Klimesova, K., Sokol, D., Hudcovic, T., Hrncir, T., Rossmann, P., Mrazek, J., Kopecny, J., Verdu, E.F. and Tlaskalova-Hogenova, H., 2011. Oral administration of Parabacteroidesdistasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clinical and Experimental Immunology 163: 250-259.

'Oral administration of Parabacteroidesdistasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition ' () 163 Clinical and Experimental Immunology : 250 -259.

Oral administration of Parabacteroidesdistasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota compositionClinical and Experimental Immunology163250259)| false
• 检索谷歌学术

Kwak, D.S., Jun, D.W., Seo, J.G., Chung, W.S., Park, S.-E., Lee, K.N., Khalid-Saeed, W., Lee, H.L., Lee, O.Y. and Yoon, B.C., 2014. Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease. European Journal of Gastroenterology and Hepatology 26: 1353-1359.

'Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease ' () 26 European Journal of Gastroenterology and Hepatology : 1353 -1359.

Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver diseaseEuropean Journal of Gastroenterology and Hepatology2613531359)| false
• 检索谷歌学术

Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D. and Gordon, J.I., 2005. Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the USA 102: 11070-11075.

'Obesity alters gut microbial ecology ' () 102 Proceedings of the National Academy of Sciences of the USA : 11070 -11075.

Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences of the USA1021107011075)| false
• 检索谷歌学术

Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D.A., Hirschfield, G.M., Hold, G., Quraishi, M.N., Kinross, J., Smidt, H., Tuohy, K.M., Thomas, L.V., Zoetendal, E.G. and Hart, A., 2016. The gut microbiota and host health: a new clinical frontier. Gut 65: 330-339.

'The gut microbiota and host health: a new clinical frontier ' () 65 Gut : 330 -339.

The gut microbiota and host health: a new clinical frontierGut65330339)| false
• 检索谷歌学术

Mazmainan, S.K., Liu, C.H., Tzianabos, A.O. and Kasper, D.L., 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of host immune system. Cell 122: 107-118.

'An immunomodulatory molecule of symbiotic bacteria directs maturation of host immune system ' () 122 Cell : 107 -118.

An immunomodulatory molecule of symbiotic bacteria directs maturation of host immune systemCell122107118)| false
• 检索谷歌学术

Mondot, S., Kang, S., Furet, J.P., Aguirre de Carcer, D., McSweeney, C., Morrison, M., Marteau, P., Dore, J. and Leclerc, M., 2011. Highlighting new phylogenetic specificities of Crohn’s disease microbiota. Inflammatory Bowel Disease 17: 185-192.

'Highlighting new phylogenetic specificities of Crohn’s disease microbiota ' () 17 Inflammatory Bowel Disease : 185 -192.

Highlighting new phylogenetic specificities of Crohn’s disease microbiotaInflammatory Bowel Disease17185192)| false
• 检索谷歌学术

Ridlon, J.M., Alves, J.M., Hylemon, P.B. and Bajaj, J.S., 2013. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes 4: 382-387.

'Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship ' () 4 Gut Microbes : 382 -387.

Cirrhosis, bile acids and gut microbiota: unraveling a complex relationshipGut Microbes4382387)| false
• 检索谷歌学术

Sevilla, M.A., Voces, F., Carrón, R., Guerrero, E.I., Ardanaz, N., San Román, L., Arévalo, M.A. and Montero, M.J., 2004. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal. Life Science 75: 881-889.

'Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal ' () 75 Life Science : 881 -889.

Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawalLife Science75881889)| false
• 检索谷歌学术

Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J. and Furet, J.P., 2011. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6: e16393.

'Microbial dysbiosis in colorectal cancer (CRC) patients ' () 6 PLoS ONE : e16393.

Microbial dysbiosis in colorectal cancer (CRC) patientsPLoS ONE6e16393)| false
• 检索谷歌学术

White, W.B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J. and Weber, M.A., 2003. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension 41: 1021-1026.

'Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension ' () 41 Hypertension : 1021 -1026.

Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertensionHypertension4110211026)| false
• 检索谷歌学术

Yamaguchi, T., Kakefuda, R., Tanimoto, A., Watanabe, Y. and Tajima, N., 2012. Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide. Inflammation Research 61: 445-454.

'Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide ' () 61 Inflammation Research : 445 -454.

Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomideInflammation Research61445454)| false
• 检索谷歌学术

Yoon, J.S., Sohn, W., Lee, O.Y., Lee, S.P., Lee, K.N., Jun, D.W., Lee, H.L., Yoon, B.C., Choi, H.S and Chung, W.S., 2014. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Journal of Gastroenterology and Hepatology 29: 52-59.

'Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial ' () 29 Journal of Gastroenterology and Hepatology : 52 -59.

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trialJournal of Gastroenterology and Hepatology295259)| false
• 检索谷歌学术

Zhang, J.M. and An, J., 2007. Cytokines, inflammation and pain. International Anesthesiology Clinics 45: 27-37.

'Cytokines, inflammation and pain ' () 45 International Anesthesiology Clinics : 27 -37.

Cytokines, inflammation and painInternational Anesthesiology Clinics452737)| false
• 检索谷歌学术